Latest Research Confirms That Triticum's L-Mesitran Honey Products Show Antibacterial Efficacy Against Antibiotic Resistant Bacteriae
Honey based products for wound care proved to be highly effective against strains of antibiotic bacteriae including ESBL.
Maastricht, Netherlands, December 16, 2010 --(PR.com)-- Antibiotic resistance in Gram-positive as well as Gram-negative micro organisms is a growing problem worldwide. The prevalence of Methicillin resistant Staphylococcus aureus (MRSA) and Gram negatives producing an Extended Spectrum beta-lactamase (ESBL) is steadily increasing during the past decades. Antibiotic use is generally considered the main risk factor for antibiotic resistance. Efforts to reduce the use of antimicrobial agents are therefore warranted.
Dr. Ellen Stobberingh, PhD, an authority on antibiotic resistant bacteriae from the Maastricht University Hospital (AZM) in The Netherlands researched the antibacterial activity of the honey based products L-Mesitran Ointment and Soft which are manufactured by Triticum Exploitatie BV (The Netherlands). The honey products have been used in wound care for a number of years with great success.
The AZM Medical Microbiology Department tested the activity of both products against clinical isolates of Staph. aureus, Ps. aeruginosa, Kl. pneumoniae and E. Coli; all bacteriae were antibiotic resistant and Kl. pneumoniae and E. Coli were ESBL producing strains. The honey based products were tested using controls and comparisons against other honey products (also Manuka). The test results were obtained in a study that had the product and bacteriae incubated for a 24hour period.
L-Mesitran Soft showed to have the highest antibacterial activity against all the bacteriae at the lowest dilution, followed by L-Mesitran Ointment. The outcome of this test proves that L-Mesitran Ointment and Soft are very effective against antibiotic resistant bacteriae. This is a valuable contribution in Triticum's efforts to reduce the use of antibiotics. The test also shows that L-Mesitran is the best choice in combating antibiotic resistant bacteriae.
Compared to antibiotics, the use of honey products is safe and without adverse effects for the treatment of infected wounds. The tested products can achieve the same goal as antibiotics: reducing the bacterial burden in a wound. Honey has as an added benefit that it can speed up wound healing and therefore (apart from lower material costs) can provide a cost effective therapy. Honey, and in particular the tested products, does therefore provide an attractive alternative for the use of (topical) antibiotics in the management of wound infections.
###
Dr. Ellen Stobberingh, PhD, an authority on antibiotic resistant bacteriae from the Maastricht University Hospital (AZM) in The Netherlands researched the antibacterial activity of the honey based products L-Mesitran Ointment and Soft which are manufactured by Triticum Exploitatie BV (The Netherlands). The honey products have been used in wound care for a number of years with great success.
The AZM Medical Microbiology Department tested the activity of both products against clinical isolates of Staph. aureus, Ps. aeruginosa, Kl. pneumoniae and E. Coli; all bacteriae were antibiotic resistant and Kl. pneumoniae and E. Coli were ESBL producing strains. The honey based products were tested using controls and comparisons against other honey products (also Manuka). The test results were obtained in a study that had the product and bacteriae incubated for a 24hour period.
L-Mesitran Soft showed to have the highest antibacterial activity against all the bacteriae at the lowest dilution, followed by L-Mesitran Ointment. The outcome of this test proves that L-Mesitran Ointment and Soft are very effective against antibiotic resistant bacteriae. This is a valuable contribution in Triticum's efforts to reduce the use of antibiotics. The test also shows that L-Mesitran is the best choice in combating antibiotic resistant bacteriae.
Compared to antibiotics, the use of honey products is safe and without adverse effects for the treatment of infected wounds. The tested products can achieve the same goal as antibiotics: reducing the bacterial burden in a wound. Honey has as an added benefit that it can speed up wound healing and therefore (apart from lower material costs) can provide a cost effective therapy. Honey, and in particular the tested products, does therefore provide an attractive alternative for the use of (topical) antibiotics in the management of wound infections.
###
Contact
Triticum Exploitatie B.V.
Joost Postmes
+31 43 325 17 73
www.l-mesitran.com
Joost Postmes
+31 43 325 17 73
www.l-mesitran.com
Contact
Categories